舒尼替尼
卡波扎尼布
医学
无容量
肾细胞癌
内科学
肿瘤科
泌尿科
酪氨酸激酶抑制剂
癌症
免疫疗法
作者
Toni K. Choueiri,Thomas Powles,Mauricio Burotto,Bernard Escudier,María T. Bourlon,Bogdan Żurawski,Víctor Manuel Oyervides-Juárez,James J. Hsieh,Umberto Basso,Amishi Y. Shah,Cristina Suárez,Alketa Hamzaj,Jeffrey C. Goh,Carlos H. Barrios,Martin Eduardo Richardet,Camillo Porta,Rubén Dario Kowalyszyn,Juan P. Feregrino,Jakub Żołnierek,David Pook
标识
DOI:10.1056/nejmoa2026982
摘要
The efficacy and safety of nivolumab plus cabozantinib as compared with those of sunitinib in the treatment of previously untreated advanced renal-cell carcinoma are not known.
科研通智能强力驱动
Strongly Powered by AbleSci AI